Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy
Boya Peng, Trinh Mai Nguyen, Migara Kavishka Jayasinghe, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 4
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

The role of extracellular vesicles in cancer
Raghu Kalluri, Kathleen M. McAndrews
Cell (2023) Vol. 186, Iss. 8, pp. 1610-1626
Closed Access | Times Cited: 284
Engineered extracellular vesicles and their mimetics for cancer immunotherapy
Chunping Liu, Yichao Wang, Longmei Li, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 679-698
Closed Access | Times Cited: 103
Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles
Phuong H. D. Nguyen, Migara Kavishka Jayasinghe, Anh Hong Le, et al.
ACS Nano (2023) Vol. 17, Iss. 6, pp. 5187-5210
Closed Access | Times Cited: 97
Exploiting RIG-I-like receptor pathway for cancer immunotherapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 70
Immunological nanomaterials to combat cancer metastasis
Yuanbo Pan, Junjie Cheng, Yang Zhu, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 12, pp. 6399-6444
Closed Access | Times Cited: 19
Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles
Xiao Cheng, Brian S. Henick, Ke Cheng
ACS Nano (2024) Vol. 18, Iss. 9, pp. 6748-6765
Closed Access | Times Cited: 17
Extracellular vesicle‐based nucleic acid delivery
Mei Lu, Wanxuan Shao, Haonan Xing, et al.
Deleted Journal (2023) Vol. 1, Iss. 2
Open Access | Times Cited: 34
Extracellular Vesicles as New Players in Drug Delivery: A Focus on Red Blood Cells-Derived EVs
Sara Biagiotti, Faiza Abbas, Mariele Montanari, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 365-365
Open Access | Times Cited: 23
Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities
Jilong Cao, Gang Lv, Wei Fang
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 14
A comprehensive review of engineered exosomes from the preparation strategy to therapeutic applications
Xiying Fan, Yiwen Zhang, Wenshuai Liu, et al.
Biomaterials Science (2024) Vol. 12, Iss. 14, pp. 3500-3521
Closed Access | Times Cited: 11
Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of Cancer
Xin Luo, Kathleen M. McAndrews, Raghu Kalluri
ACS Nano (2025)
Closed Access | Times Cited: 1
Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy
Xinyi Liu, Chunxiu Xiao, Kai Xiao
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Red blood cell extracellular vesicles deliver therapeutic siRNAs to skeletal muscles for treatment of cancer cachexia
Boya Peng, Yuqi Yang, Zhiyuan Wu, et al.
Molecular Therapy (2023) Vol. 31, Iss. 5, pp. 1418-1436
Open Access | Times Cited: 17
Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies
Siena M. Mantooth, Yara Abdou, Ana Rosa Saez-Ibañez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Dendritic cell‐targeted delivery of antigens using extracellular vesicles for anti‐cancer immunotherapy
Xuan Dang, Cao Dai Phung, Claudine Ming Hui Lim, et al.
Cell Proliferation (2024) Vol. 57, Iss. 7
Open Access | Times Cited: 6
Engineered biological nanoparticles as nanotherapeutics for tumor immunomodulation
Juwita N. Rahmat, Jiayi Liu, Taili Chen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 11, pp. 5862-5903
Open Access | Times Cited: 6
Endosomal escape of nucleic acids from extracellular vesicles mediates functional therapeutic delivery
Tuan Thach Pham, Huan Chen, Phuong H. D. Nguyen, et al.
Pharmacological Research (2023) Vol. 188, pp. 106665-106665
Open Access | Times Cited: 15
PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA
Yingying Xu, Yijing Zheng, Xuqiu Ding, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 15
Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy
Migara Kavishka Jayasinghe, Chang Gao, Gracemary Yap, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 21639-21661
Open Access | Times Cited: 13
Promising Combinatorial Therapeutic Strategies against Non-Small Cell Lung Cancer
Prabhjot Kaur, Santosh Kumar Singh, Manoj K. Mishra, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2205-2205
Open Access | Times Cited: 5
Nanobody-based drug delivery systems for cancer therapy
Lin Liu, Bin Tu, Yao Sun, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113562-113562
Closed Access
Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges
Rong Du, Chen Wang, Ling Zhu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2236-2236
Open Access | Times Cited: 21
Endocytosis of red blood cell extracellular vesicles by macrophages leads to cytoplasmic heme release and prevents foam cell formation in atherosclerosis
Thach Tuan Pham, Anh Hong Le, Cong Phi Dang, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 8
Open Access | Times Cited: 11
Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy
Lihong Wang-Bishop, Mohamed Wehbe, Lucinda E. Pastora, et al.
ACS Nano (2024) Vol. 18, Iss. 18, pp. 11631-11643
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top